CST Pharma Ltd: UK Public Sector Contracts Won & Awards

Companies House: Private Limited CompanyWalsallNationwide (UK)Main market: Pharmaceutical products

Official UK PPONPBDW-5911-ZDBQCompanies House04212740 ↗ · Active

Where they win
i

73 awards (71 for a named lot, 97%, 2 for a whole procedure with no lot named) · top CPV classes, shares of all 73 awards. An award may cover more than one class.

3360 Pharmaceutical products72 awards · 99% · 70 awards naming a lot + 2 whole-procedure awards
3369 Various medicinal products1 award · 1% · awards naming a lot
Attributable award value
i
£2.2mOn 9 of 73 award records; the five largest make 96%. Largest rows below.
Typical attributable award
i
£44k middle valuerobust · n=9

Where their buyers are
i

ITL1 region of the buyer office · known for 57 of 57 awarded procedures · each procedure counts once

Greater London23 procedures · 40%
Scotland17 procedures · 30%
Wales (Cymru)10 procedures · 18%
North West England5 procedures · 9%
East Midlands2 procedures · 4%

Bidding record
i

Procurement Act 2023 award notices name every bidder · 8 notices name this supplier since 20 Aug 2025 · observed bids, not an estimate

Contract lots contested
i
0 won · 0 lostFewer than three decided lots: no rate is claimed.
Framework / DPS places
i
5 of 8
Authorities bid for
i
1

Bidder names come from Procurement Act 2023 award notices, which list every bidder (from 2025). Older notices name no bidders, so earlier contests do not appear here. Latest ten notices shown.

Who they sell to
i

Authorities named on this supplier’s published awards · ranked by distinct procedures · a framework or DPS adds one award record per appointed supplier

Authority type · official UK type when published, else name/id class, else not classified · by award records (a single panel can dominate)
i
  • NHS & health96%(70 awards)
    70 of 73 awards are NHS & health (96%).
  • Type not classified4%(3 awards)
    3 of 73 awards are Type not classified (4%).

Share = of the 57 procedures with an award naming this supplier. Last activity = award date, or notice publication when no award date was published.

Contracts ending
i

65 of 75 awards carry an end date, 23 estimated from the duration · not a retender forecast

Soonest 10 of 15.

Recent awards

Latest 30 of 73 award records naming this supplier

Contracts Finder adds 2 more procedures won by this supplier, mostly below the Find a Tender threshold or from before 2025. Each is counted once beside any Find a Tender copy; they are in the totals, not in this list.

Award / procedureAuthorityAwardedPublished value
Generic Drugs – Tablets and Capsules 2NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)17 Sept 2026£1,597,360
joint award · 27 suppliers
Lot 2 - CM/PHG/24/2714/02 Hospital Only products DLN & DNW regionsNHS England27 Aug 2026£393,331,872
framework ceiling · 1 of 101 appointed suppliers
Lot 1 - CM/PHR/25/5730/01 - NHS Branded Medicines Tranche A for Midlands & EastNHS England15 Jun 2026£665,389,588
framework ceiling · 1 of 25 appointed suppliers
NHS National Branded Interim - 1 June 2026NHS England10 Apr 2026£529,090,780
framework ceiling · 1 of 51 appointed suppliers
Lot 2 - CM/PHG/23/5699/02 CM/PHG/23/5699/02 Hospital only productsNHS England13 Jan 2026£403,702,000
framework ceiling · 1 of 104 appointed suppliers
NHS National Framework for Transition products (Nilotinib and Ticagrelor)NHS England12 Jun 2025£22,097,000
framework ceiling · 1 of 8 appointed suppliers
NHS National Framework for Transition products (Nilotinib and Ticagrelor)NHS England12 Jun 2025£22,097,000
framework ceiling · 1 of 8 appointed suppliers
Analgesics, Anaesthetics & MSD GenericsThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£2,267,492 †
framework ceiling · 1 of 2 appointed suppliers
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026NHS EnglandNot published£665,389,588 †
framework ceiling · 1 of 24 appointed suppliers
Branded HIV MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Not published£79,068,428 †
framework ceiling · 1 of 5 appointed suppliers
About this data
  • One profile per supplier. Built from award and contract notices that name this supplier; different spellings and registration numbers of the same company are merged into this profile.
  • Values are published values. The table mirrors what the notice published: framework ceilings and joint awards are labelled and never counted as this supplier's money, and † marks a value taken from the contract notice when the award published none. Only awards made to this supplier alone count towards its value, excluding VAT. It is not turnover.
  • Regions in the buyer chart describe the buyer office, not where the work is delivered or the supplier’s registered address.
  • Contract end dates. Published on 42 of 75 awards, estimated from the published duration on 23 more (marked “estimated”); those feed “Contracts ending”. Published values in that list come from either source; Contracts Finder figures are shown as published and stay out of this profile’s money totals.
  • Source. Official UK public procurement notices (Find a Tender, Contracts Finder and Public Contracts Scotland), reused under the Open Government Licence v3.0, updated through the day and rebuilt nightly. Not every figure uses every feed, and each one shows how many records it rests on: see the methodology. Spotted something wrong? Tell us.